Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy

Area of Science:

• Cardiovascular diagnostics
• Lipid metabolism analysis
• Clinical chemistry

Background:

• Recent guidelines suggest nonfasting lipid profiles may impact LDL-C estimation accuracy.
• The Friedewald method (LDL-C_F) uses fixed ratios, potentially limiting accuracy in nonfasting states.
• A novel LDL-C estimation (LDL-C_N) employs patient-specific ratios for improved adaptability.

Purpose of the Study:

• To evaluate the accuracy of a novel LDL-C estimation method (LDL-C_N) compared to the Friedewald method (LDL-C_F) in both fasting and nonfasting patients.
• To assess the impact of fasting status on LDL-C estimation accuracy.
• To determine the performance of LDL-C_N and LDL-C_F across various LDL-C and triglyceride levels.

Main Methods:

• Utilized a large US cross-sectional dataset (1,545,634 patients) including both fasting and nonfasting samples.
• Directly measured LDL-C (LDL-C_D) via rapid ultracentrifugation for accuracy assessment.
• Defined accuracy as the percentage of directly measured LDL-C within categories of estimated LDL-C (LDL-C_N or LDL-C_F).

Main Results:

• The novel LDL-C_N method demonstrated higher accuracy (87%-94%) than Friedewald (71%-93%) across all clinical LDL-C categories in both fasting and nonfasting samples (P≤0.001).
• For LDL-C <70 mg/dL, nonfasting LDL-C_N accuracy (92%) significantly outperformed LDL-C_F (71%; P<0.001).
• LDL-C_N showed superior accuracy to LDL-C_F in nonfasting patients with high triglycerides (200-399 mg/dL), particularly for LDL-C <70 mg/dL (82% vs 37%; P<0.001).

Conclusions:

• The novel adaptable LDL-C estimation method offers improved accuracy over the Friedewald method, especially in nonfasting samples.
• LDL-C_N provides a particular accuracy advantage in patients with low LDL-C and high triglyceride levels.
• These findings have significant implications for clinical practice, guideline development, and laboratory diagnostics.